Organization

Hôpital Robert Schuman, Service de Pneumologie, Metz, France

2 abstracts

Abstract
IFCT-2105 lurbiclin real-world effectiveness and treatment sequences in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC) who received lurbinectedin as part of the French Early Access Program (EAP-ATU).
Org: Institut du Thorax Curie Montsouris, Institut Curie, Paris, and UVSQ, Paris Saclay University, Versailles, France, Institut Curie, Saint Cloud, France, Univ Rouen Normandie, CHU Rouen, Inserm CIC-CRB 1404,
Abstract
Two-year lung cancer survival between 2000 to 2020: Results from 3 French nationwide cohorts.
Org: Service de Pneumologie, Groupe Hospitalier de la Région Mulhouse Sud-Alsace, hôpital Émile-Muller, Mulhouse, France, CHI De Creteil, Créteil, France, HIA SAINTE ANNE, Toulon, France, Hospital Center De La Cote Basque, Bayonne, France, Centre Hospitalier, Le Mans, France,